A method of treating a condition associated with bone loss or low bone density or for inhibiting osteoclast differentiation and stimulation, bone resorption, or loosening of a prosthetic device in a mammal, comprising administering to said mammal an effective amount a compound or combination of compounds of the general formula (I)
- R1-A-NH—CH(R2)—CO—R3 (1)
- wherein,
- R1 is NH2—C(NH)—NH—(CH2)m—CO, an acyl residue containing a hydroxylated coumarin moiety, or Ar—N—, where X is (CH2)m—O—CO, (CH2)m—SO2—CH═CH—CO, CH═CH—CO, CO-oxirane-CO, CO—CH═CH—CO, CH2—CH═CH—CO or (CH2)m—CO, and m is an integer of 0 to 5;
- A is a bond or is one or more of Arg, Val or Leu;
- R2 is isopropyl or isobutyl;
- and
- R3 is NH—(CH2)m—NH—C(NH)—NH2, Phe-NH2, or NH—CH(R4) (CH2)m—NH-D, where R4 is a C1-C6 alkyl and D is CO—CH═CH—Ar, CO—CH═CH—SO2—(CH2)m—Ar, or Cum-Phe-, where Ar is aryl or heteroaryl, Cum is an acyl residue containing hydroxylated coumarin moiety, and m is an integer of 0 to 5;
- the compound being a single stereoisomer or a mixture of different stereoisomers, or a pharmaceutically acceptable salt thereof.